Imbruvica (ibrutinib tablets, capsules, and oral suspension) — Cigna
Graft-Versus-Host Disease, Chronic
Initial criteria
- Patient is age ≥ 1 year
- Patient has tried at least one systemic medication for graft-versus-host disease
Approval duration
1 year